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Background: Neuregulin (NRG) and vascular endothelial growth factor (VEGF) are angiogenic factors that positively regulate each other’s 
expression in vitro. We hypothesized circulating NRG and VEGF levels would vary across patient with coronary artery disease (CAD) in relation to 
disease severity, and that VEGF and NRG would correlate.
Methods: Serum and plasma levels of NRG and VEGF were measured by enzyme-linked immunoassay in 60 patients undergoing cardiac 
catheterization. Severity of CAD was calculated from angiography results using a modified Duke jeopardy score, which accounts for location, degree 
of stenosis, and number of vessels involved. Severity score of 0=no CAD, 2-4 mild, 6-8 moderate, and 10-12 severe CAD. The correlations between 
serum and plasma levels of NRG-1 and the differences in serum or plasma levels of NRG-1 with different severities of CAD were analyzed.
Results: Serum and plasma levels of NRG and VEGF were detectable in all 60 patients. Serum and plasma NRG correlated (r=0.73 p<0.01). Across 
all subjects we found no relationship between NRG and VEGF. There was a statistically significant difference in serum NRG levels among patients with 
varying severity of CAD (p=0.048). There was no difference in plasma or serum VEGF levels in patients according to severity of CAD.
Conclusions: Serum and plasma NRG are detectable in patients with CAD. We observed lower levels of NRG 
in subjects with more advanced CAD in which the clinical and biological significance remains to be determined.
